# Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection

> **NCT03479294** · — · TERMINATED · sponsor: **West China Hospital** · enrollment: 9 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung
- Chemotherapy, Adjuvant

## Interventions

- **DRUG:** Shenlingcao Oral Liquid

## Key facts

- **NCT ID:** NCT03479294
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-28
- **Primary completion:** 2018-09-10
- **Final completion:** 2018-09-10
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Because of the difficulty of research operation, we changed to another research design.
- **Last updated:** 2019-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03479294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03479294, "Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03479294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*